The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia - PubMed (original) (raw)

The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia

M H Kollef et al. Chest. 1998 Feb.

Abstract

Study objective: To determine the influence of mini-BAL culture results on subsequent changes in antibiotic therapy and patient outcomes.

Design: Prospective, single-center, cohort study.

Setting: Medical ICU of Barnes-Jewish Hospital, St. Louis, a university-affiliated teaching hospital.

Patients: One hundred thirty mechanically ventilated patients undergoing mini-BAL for suspected ventilator-associated pneumonia (VAP).

Interventions: Mini-BAL, prospective patient surveillance, and data collection.

Measurements and results: Sixty (46.2%) patients had mini-BAL cultures that yielded at least one pathogen potentially accounting for the clinically suspected episode of VAP (64 bacterial, 3 viral, 2 fungal). Among the 60 patients with microbiologically positive mini-BAL cultures, 44 (73.3%) were classified as receiving inadequate antibiotic therapy (ie, identification of a microorganism resistant to the prescribed antibiotic regimen). Prior antibiotic administration or its absence remained unchanged in 51 (39.2%) patients based on the mini-BAL culture results, while in another 51 (39.2%) patients, antibiotic therapy was either begun (n=7) or the existing antibiotic regimen was changed (n=44), and in the remaining 28 (21.6%) patients, antibiotic therapy was discontinued altogether. The hospital mortality rates of these three groups were statistically different: 33.3%, 60.8%, and 14.3%, respectively (p<0.001). The most common pattern of antibiotic resistance resulting in an antibiotic change following mini-BAL was the identification of a Gram-negative bacteria resistant to a prescribed third-generation cephalosporin in 23 of 44 (52.3%) patients. Twenty-one of these 23 patients (91.3%) received prior therapy with a cephalosporin class antibiotic during the same hospitalization. Having an immunocompromised state (adjusted odds ratio [OR]=2.45; 95% confidence interval, 1.56 to 3.85; p=0.047) and the presence of a pathogen in the mini-BAL culture resistant to the empirically prescribed antibiotic regimen (adjusted OR=3.28; 95% confidence interval, 2.12 to 5.06; p=0.006) were identified as risk factors independently associated with hospital mortality by logistic regression analysis.

Conclusions: These data suggest that antibiotic selection prior to obtaining the results of lower airway cultures is an important determinant of outcome for patients with suspected VAP. A delay in initiating adequate antibiotic therapy was associated with a greater mortality. Therefore, the initial selection of antibiotics for the empiric treatment of VAP should be broad enough to cover all likely pathogens, including antibiotic-resistant bacteria. This appears to be especially important in patients having received prior antibiotics.

PubMed Disclaimer

Cited by

Immediate vs. culture-initiated antibiotic therapy in suspected non-severe ventilator-associated pneumonia: a before-after study (DELAVAP).
Martin M, Forveille S, Lascarrou JB, Seguin A, Canet E, Lemarié J, Agbakou M, Desmedt L, Blonz G, Zambon O, Corvec S, Le Thuaut A, Reignier J. Martin M, et al. Ann Intensive Care. 2024 Feb 27;14(1):33. doi: 10.1186/s13613-024-01243-z. Ann Intensive Care. 2024. PMID: 38411756 Free PMC article.
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.
Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O'Grady NP, Bartlett JG, Carratalà J, El Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL. Kalil AC, et al. Clin Infect Dis. 2016 Sep 1;63(5):e61-e111. doi: 10.1093/cid/ciw353. Epub 2016 Jul 14. Clin Infect Dis. 2016. PMID: 27418577 Free PMC article.
Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset.
Vallés J, Pobo A, García-Esquirol O, Mariscal D, Real J, Fernández R. Vallés J, et al. Intensive Care Med. 2007 Aug;33(8):1363-8. doi: 10.1007/s00134-007-0721-0. Epub 2007 Jun 9. Intensive Care Med. 2007. PMID: 17558495
Optimal use of antibiotics for intubation-associated pneumonia.
Rello J, Diaz E. Rello J, et al. Intensive Care Med. 2001 Feb;27(2):337-9. doi: 10.1007/s001340000755. Intensive Care Med. 2001. PMID: 11396275 No abstract available.
The Use of Diuretic in Mechanically Ventilated Children with Viral Bronchiolitis: a Cohort Study.
Agasthya N, Chromey K, Hertzog JH, Chauhan JC. Agasthya N, et al. J Crit Care Med (Targu Mures). 2021 May 12;7(2):97-103. doi: 10.2478/jccm-2021-0008. eCollection 2021 Apr. J Crit Care Med (Targu Mures). 2021. PMID: 34722910 Free PMC article.

The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia - PubMed (original) (raw)